Clinical Trials List
2025-12-27 - 2032-05-15
Phase III
Not yet recruiting3
ICD-10C54.8
Malignant neoplasm of overlapping sites of corpus uteri
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9182.8
Malignant neoplasm of other specified sites of body of uterus
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 吳佩瑩 無
- Meng-Ru Shen 無
- Keng-Fu Hsu 無
- 黃蘭茵 無
- 梁玉玲 無
- Cheng-Yang Chou 無
- 林語涵 無
- 鄭雅敏 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
700 participants
